Abbott: Heart Failure trials

The registry lists 106 Heart Failure studies with Abbott as lead sponsor. 5 are open to participants now and 43 have results posted.

Early Phase 1 1Phase 1 1Phase 2 3Phase 3 5Phase 4 4No phase 93(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity TherapyCompletedNCT00187252Not applicable
• B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Cardiac Defibrillator (ICD) Back-Up in Heart Failure PatientsCompletedNCT00187213Not applicable
• DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)CompletedNCT00187187Not applicable
• Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart FailureCompletedNCT00160134Phase 2
• RethinQ Study - Evaluating Pacing in Heart Failure PatientsCompletedNCT00132977Phase 3
• Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.CompletedNCT00048425Phase 3